ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Revive Therapeutics Ltd (QB)

Revive Therapeutics Ltd (QB) (RVVTF)

0.0075
0.0015
(25.00%)
Closed January 31 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.0075
Bid
0.0048
Ask
0.0154
Volume
134,088
0.0068 Day's Range 0.0084
0.005 52 Week Range 0.0279
Market Cap
Previous Close
0.006
Open
0.0084
Last Trade
25000
@
0.0075
Last Trade Time
Financial Volume
$ 1,005
VWAP
0.007493
Average Volume (3m)
463,976
Shares Outstanding
418,564,269
Dividend Yield
-
PE Ratio
-5.97
Earnings Per Share (EPS)
-0.01
Revenue
-
Net Profit
-5.62M

About Revive Therapeutics Ltd (QB)

Sector
Pharmaceutical Preparations
Industry
Unit Inv Tr, Closed-end Mgmt
Headquarters
Toronto, Ontario, Can
Founded
2014
Revive Therapeutics Ltd (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker RVVTF. The last closing price for Revive Therapeutics (QB) was $0.01. Over the last year, Revive Therapeutics (QB) shares have traded in a share price range of $ 0.005 to $ 0.0279.

Revive Therapeutics (QB) currently has 418,564,269 shares outstanding. The market capitalization of Revive Therapeutics (QB) is $2.51 million. Revive Therapeutics (QB) has a price to earnings ratio (PE ratio) of -5.97.

RVVTF Latest News

Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19

  Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19   TORONTO, Canada -- April 18, 2022 -- InvestorsHub NewsWire -- Revive...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

  Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   TORONTO, Canada -- April 12, 2022 -- InvestorsHub NewsWire -- Revive...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   Expected to seek DSMB approval to proceed with EUA application to the FDA in...

HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research

                              HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive...

Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation

 Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation  TORONTO, February 15, 2022 -- Revive...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19Ethics Committee approval to proceed with Phase 3 clinical trial in Turkey13 clinical sites selected to...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 701 subjects dosed to date Initiating enrollment activities in Turkey as part of its...

Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

 Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs IRB approval to initiate Phase 2 study for methamphetamine abuse disorders Advancing psilocybin oral thin film...

Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19

 Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19 Approximately 700 subjects participated in the enrollment periodExpected to begin subject enrollment...

Revive Therapeutics Announces Published Research Results on Bucillamine as Potential Inhibitor of SARS-CoV-2 Infection Delta Variant

 Revive Therapeutics Announces Published Research Results on Bucillamine as Potential Inhibitor of SARS-CoV-2 Infection Delta Variant TORONTO, November 16, 2021 -- InvestorsHub NewsWire -- Revive...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.002447.05882352940.00510.00850.0051029530.00598495CS
40.002344.23076923080.00520.00850.0052500970.00610595CS
120.001422.95081967210.00610.0120.0054639760.00698507CS
26-0.0005-6.250.0080.01350.0053923290.00717032CS
52-0.015-66.66666666670.02250.02790.0053360100.01143877CS
156-0.2075-96.5116279070.2150.390.0054233150.1015595CS
260-0.0281-78.93258426970.03560.720.00510521070.27470216CS

RVVTF - Frequently Asked Questions (FAQ)

What is the current Revive Therapeutics (QB) share price?
The current share price of Revive Therapeutics (QB) is $ 0.0075
How many Revive Therapeutics (QB) shares are in issue?
Revive Therapeutics (QB) has 418,564,269 shares in issue
What is the market cap of Revive Therapeutics (QB)?
The market capitalisation of Revive Therapeutics (QB) is USD 2.51M
What is the 1 year trading range for Revive Therapeutics (QB) share price?
Revive Therapeutics (QB) has traded in the range of $ 0.005 to $ 0.0279 during the past year
What is the PE ratio of Revive Therapeutics (QB)?
The price to earnings ratio of Revive Therapeutics (QB) is -5.97
What is the reporting currency for Revive Therapeutics (QB)?
Revive Therapeutics (QB) reports financial results in CAD
What is the latest annual profit for Revive Therapeutics (QB)?
The latest annual profit of Revive Therapeutics (QB) is CAD -5.62M
What is the registered address of Revive Therapeutics (QB)?
The registered address for Revive Therapeutics (QB) is 82 RICHMOND STREET EAST, SUITE 105, TORONTO, ONTARIO, M5C 1P1
What is the Revive Therapeutics (QB) website address?
The website address for Revive Therapeutics (QB) is www.revivethera.com
Which industry sector does Revive Therapeutics (QB) operate in?
Revive Therapeutics (QB) operates in the UNIT INV TR, CLOSED-END MGMT sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NXGBNxGen Brands Inc (CE)
$ 0.003
(299,900.00%)
180.55k
DOCKFBeyond Med Technologies Inc (PK)
$ 0.055
(54,900.00%)
3.05k
SDCCQSmileDirectClub Inc (CE)
$ 0.0004
(39,900.00%)
52.05k
LTFDLittlefield Corporation (CE)
$ 0.1525
(38,025.00%)
240
SGMDSugarmade Inc (CE)
$ 0.0003
(29,900.00%)
5.94k
RTNBroot9B Holdings Inc (CE)
$ 0.000001
(-99.97%)
666
THMOThermoGenesis Holdings Inc (CE)
$ 0.000001
(-99.86%)
250
DOMWFPrime Drink Group Corporation (PK)
$ 0.0012
(-99.08%)
311.03k
TTCMTautachrome Inc (CE)
$ 0.000001
(-99.00%)
125.07k
MITJFMint Corporation (CE)
$ 0.0001
(-99.00%)
12k
HCMCHealthier Choices Management Corporation (PK)
$ 0.000001
(0.00%)
316.07M
HMBLHUMBL Inc (PK)
$ 0.0007
(0.00%)
218.85M
GRLFGreen Leaf Innovations Inc (PK)
$ 0.00015
(-25.00%)
210.68M
RONNRonn Motor Group Inc (PK)
$ 0.0003
(0.00%)
171.31M
AITXArtificial Intelligence Technology Solutions Inc (PK)
$ 0.00275
(-1.79%)
134.31M

RVVTF Discussion

View Posts
govprs govprs 2 weeks ago
Yep.  Some people can't get enough 


👍️0
JoeBenson JoeBenson 3 weeks ago
New? The metapneumovirus is not new...nice try. Besides do you want MF to take more of your money? Didn't learn your lesson the last time?
👍️0
JoeBenson JoeBenson 3 weeks ago
I see rickthedickstereo is back.
👍️0
govprs govprs 3 weeks ago
lol.  Michael Frank is a thief 
👍️0
lolroflmao lolroflmao 3 weeks ago
NEWS: Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure

January 08, 2025 07:30 ET | Source: Revive Therapeutics Ltd.


https://www.globenewswire.com/news-release/2025/01/08/3006148/0/en/Revive-Therapeutics-Provides-Update-on-Research-Study-Evaluating-Bucillamine-for-Nerve-Agent-Exposure.html
👍️0
its only money its only money 4 weeks ago
Hey RVVTF board,havent been here in a long time and see we are not millionaires yet but I just seen this about China........ Hospitals in China are overwhelmed with patients as cases of the new HMPV virus rise. There are concerns that it could trigger a new epidemic, similar to COVID-19, informs NDTV.
According to the publication, China has experienced a sudden spike in respiratory illnesses in recent days, which "reminding people of a similar surge during COVID-19.".......do we get another chance at some movement .
😱 1 😷 1
govprs govprs 1 month ago
Lol 
👍️0
rickstereo3333 rickstereo3333 1 month ago
Things may look much better for Small Pharmacos with the new incoming admin (if they allow JFKs confirmation) because the playing field should be more equitable as opposed to the past.

Hopefully Bucillamine will get looked over once again by the authorities as a potentially safe and effective multi use therapeutic for a host of maladies.

AIMHOOC
👍️ 1 🙏 1
Classic Warrior Classic Warrior 2 months ago
That's a relief. I'm down a few cents.
👍️0
KimKhaos5 KimKhaos5 2 months ago
Shroom Boom. Psychedelic Therapy. 
👍️0
Milesblue42 Milesblue42 3 months ago
NO PUMP....but a Crazy thought....

1st this is in no way a PUMP Idea.

2nd We don't know if RFK Jr will be confirmed. But just the mention of him being selected by DT sent a lot of BP stocks down.

3rd if RFK Jr is confirmed somehow and his preference for more natural remedies would that make RVVTF finally attractive to BP?


https://www.cnbc.com/2024/11/14/vaccine-maker-stocks-fall-as-trump-chooses-rfk-jr-to-lead-hhs.html
👍️0
Milesblue42 Milesblue42 3 months ago
Ceo Frank being reported as well???

Forward scamming trust bots to the SEC for making a stock appear to be a scam to newbies.

Pure Comedy 😄
👍️0
cfoofme cfoofme 3 months ago
Forward scamming trust bots to the SEC for making a stock appear to be a scam to newbies.
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 3 months ago
Price prediction
🥸 1
TRUSTUNITS1000000 TRUSTUNITS1000000 3 months ago
Shareholders post
🤓 1
TRUSTUNITS1000000 TRUSTUNITS1000000 3 months ago
Speculating, wonder if market capitalization, miracle, if goes to billions , maybe fka billion
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 3 months ago
Interesting stock price
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 3 months ago
A lot of debt
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 3 months ago
What makes you come up with $4
👍️0
Snoop_dog Snoop_dog 3 months ago
$4 might finally be her JFK at the FDA.
👍️0
Snoop_dog Snoop_dog 3 months ago
They should jump on it H5N1 next COVID.
👍️0
Snoop_dog Snoop_dog 3 months ago
Any one knows if they work on H5N1?
👍️0
lolroflmao lolroflmao 3 months ago
Revive Therapeutics Announces Publication Demonstrating Novel Therapeutic Approach of Psilocybin in Stroke Nov 12, 2024

https://revivethera.com/2024/11/revive-therapeutics-announces-publication-demonstrating-novel-therapeutic-approach-of-psilocybin-in-stroke/
👍️ 2 💥 1
lolroflmao lolroflmao 3 months ago


👍️0
Ecomike Ecomike 3 months ago
That dog is all bark and no bite. Ignore him
👎️ 1
Gatorca Gatorca 3 months ago
Maybe another possibility If Buc. work 16x nac...Promising Role of N-Acetylcysteine in Reducing Airway Mucus in COPD Patients
https://x.com/ThailandMedicaX/status/1851274249392308675
Hopefully Cw, Rio seen his reply in reddit lol etc they get it to good Use instead of up mfs a ss Monthly 30k salary
👍️0
lolroflmao lolroflmao 3 months ago
News: Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
Oct 31, 2024

https://revivethera.com/2024/10/revive-therapeutics-provides-update-on-research-study-evaluating-bucillamine-for-nerve-agent-exposure-2/
👍️ 1
TRUSTUNITS1000000 TRUSTUNITS1000000 3 months ago
One to watch
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 3 months ago
0.0001
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 3 months ago
Interesting company
👍️0
Gatorca Gatorca 4 months ago
Derrick might be a better possible Ceo at this point with Shrooms lol ) what about the possible cancer fighting Shrooms?
Ps. Sorry forgot the name of that shroom type possibility..
Pss. Waiting on my Domino's lol..but not Mf. but honestlyhope eventuallyit works our Cw ops 5 shots pizza done heheh..
👍️0
Gatorca Gatorca 4 months ago
I just hope 🙏 you ok
👍️ 1
Classic Warrior Classic Warrior 4 months ago
Yea. It's my biggest loss, but I my optimism is all but gone. Mistakes were made for sure, but hopefully, the Canadian Department of Defense will see something in the drug and save the day. I still wonder what Derrick has been doing on the psychedelic side and the weed angle. What about those patented strips? I'd say we have about a 3% chance of recovery, but I have been wrong before and hope I am again.

ps. Good luck, but profits elsewhere may be more realistic at this time.
💯 1
Gatorca Gatorca 4 months ago
Just Sucks Cw all I can say now bucy good but Chit ceo etc...
Maybe try some other stocks with some ot money
Ps. Still trying to get it back Lol..but have good chance I think will see...
👍️0
JoeBenson JoeBenson 4 months ago
Well you should know Giovanni, nobody has spewed more BS on this board than you have.
👍️0
Giovanni Giovanni 4 months ago
All Is Fine was total BS.
👍️ 2 💯 2
JoeBenson JoeBenson 4 months ago
"What false allegations did MF make?"

👍️0
Milesblue42 Milesblue42 4 months ago
What do you mean? Explain please

OMG .Oo7 how the long covid. The CEO needs to go to jail!!! Making false allegations about his product. Promises that never came true. Literally he should go to prison for financial fraud. Can't even hold a penny. MF I hope a bus comes by an pick you up. When we will get a new CEO. f joke. I hope he comes to Chicago we could show him the Chicago smile and the hospitality.

What false allegations did MF make?
👍️0
Snoop_dog Snoop_dog 4 months ago
OMG .Oo7 how the long covid. The CEO needs to go to jail!!! Making false allegations about his product. Promises that never came true. Literally he should go to prison for financial fraud. Can't even hold a penny. MF I hope a bus comes by an pick you up. When we will get a new CEO. f joke. I hope he comes to Chicago we could show him the Chicago smile and the hospitality.
💯 1
Snoop_dog Snoop_dog 4 months ago
OMG .Oo7 how the long covid. The CEO needs to go to jail!!! Making false allegations about his product. Promises that never came true. Literally he should go to prison for financial fraud. Can't even hold a penny. MF I hope a bus comes by an pick you up. When we will get a new CEO. f joke. I hope he comes to Chicago we could show him the Chicago smile and the hospitality.
👍️0
powerbattles powerbattles 4 months ago
Nobody cares and not enough volume to cover the cost issue of the news.
👍️0
lolroflmao lolroflmao 4 months ago
NEWS: Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures

SEP 18, 2024


https://revivethera.com/2024/09/revive-therapeutics-announces-strategic-focus-on-bucillamine-for-infectious-diseases-and-medical-countermeasures/
👍️ 1
medicinecat medicinecat 5 months ago
👍️ 1
Hotel Delta Hotel Delta 5 months ago
It'll go back up, buy now if you want to make a little money.
👍️0
mrfumbles mrfumbles 5 months ago
Down down down
👍️0
govprs govprs 5 months ago
Omg.
👍️0
JoeBenson JoeBenson 5 months ago
👍️0
Classic Warrior Classic Warrior 5 months ago
Almost made back all the money I lost by working overtime, PB. I haven't sold a share but hope for a miracle. If I bought the same number of shares today, I'd own 50% of the company with MF.

ps. more delays. Didn't see that coming although I'm not sure we can blame the big guy for that one. Monkeypox- here we come.
👍️0
powerbattles powerbattles 5 months ago
Bucillamine showed promise, but MF is a con man. It's very sad to see that MF is taking advantage, he treats shareholders like ATMs to cover his personal expenses. I still see many loyal shareholders posting here. At this point, it's a choice between moving on or holding out for a miracle, which could still happen.
👍️ 1
Milesblue42 Milesblue42 5 months ago
Bucillamine cures every Damn Thing

Is this the Real Deal.....this time?

Will Mr. Frank ever come through??
👍️0

Your Recent History

Delayed Upgrade Clock